{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Orlando",
      "address_1": "6700 Conroy Windermere Rd",
      "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes",
      "address_2": "Suite 140",
      "product_quantity": "2",
      "code_info": "C5812 Exp 9/8/13 and L4317 Exp 6/30/13",
      "center_classification_date": "20130711",
      "distribution_pattern": "Nationwide and PR",
      "state": "FL",
      "product_description": "Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL",
      "report_date": "20130717",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy",
      "recall_number": "D-713-2013",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "65360",
      "recall_initiation_date": "20130529",
      "postal_code": "32835-3500",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Ongoing"
    }
  ]
}